Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.200
+0.280 (7.14%)
At close: Jun 26, 2026, 4:00 PM EDT
4.060
-0.140 (-3.33%)
After-hours: Jun 26, 2026, 6:30 PM EDT
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$81,958
Profits / Employee
-$1,797,938
Market Cap
218.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Tonix Pharmaceuticals Holding | 142 |
| Voyager Therapeutics | 141 |
| Alector | 103 |
| Immunic | 95 |
| Keros Therapeutics | 87 |
| Whitehawk Therapeutics | 29 |
| Q32 Bio | 22 |
CAMP News
- 8 days ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan - TheFly
- 17 days ago - Camp4 Therapeutics Transcript: AGM 2026 - Transcripts
- 18 days ago - Camp4 Therapeutics initiated with a Buy at Chardan - TheFly
- 20 days ago - New Analysis Strengthens Mercator Gold System and Confirms High-Grade BIF Continuity - GlobeNewsWire
- 5 weeks ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder - GlobeNewsWire
- 7 weeks ago - Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c) - TheFly